600 MADISON AVENUE, SUITE 1601, NEW YORK, NY
Market cap: $32.7M (12/18/2025)
Price: $1.98
Annual Meeting of Stockholders - Director Elections Held on November 20, 2025
News
Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update
Other Events
Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance
Annual Report to Security Holders
Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
Announces Pricing of $50 Million Public Offering
Amended Quarterly Report
Q1
FY 2025
Q3
Q2
Amended Annual Report
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership